Cargando…
Characterization and quantitation of busulfan DNA adducts in the blood of patients receiving busulfan therapy
DNA alkylating drugs have been used as cancer chemotherapy with variable outcomes. The establishment of predictive biomarkers to identify patients who will effectively respond to treatment would allow for the development of personalized therapies. As the degree of interaction of alkylating drug with...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Gene & Cell Therapy
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938526/ https://www.ncbi.nlm.nih.gov/pubmed/36820303 http://dx.doi.org/10.1016/j.omto.2023.01.005 |